Tharimmune, Inc. Files 8-K: Material Definitive Agreement

Ticker: CNTN · Form: 8-K · Filed: Sep 16, 2024 · CIK: 1861657

Tharimmune, INC. 8-K Filing Summary
FieldDetail
CompanyTharimmune, INC. (CNTN)
Form Type8-K
Filed DateSep 16, 2024
Risk Levelmedium
Pages4
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: material-definitive-agreement, filing

Related Tickers: THAR

TL;DR

THARIMMUNE (THAR) filed an 8-K on 9/11 for a material definitive agreement.

AI Summary

On September 11, 2024, Tharimmune, Inc. entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosure and Financial Statements and Exhibits.

Why It Matters

This 8-K filing indicates a significant new agreement for Tharimmune, Inc., which could impact its business operations and financial future.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.

Key Players & Entities

FAQ

What is the nature of the Material Definitive Agreement Tharimmune, Inc. entered into?

The filing states that Tharimmune, Inc. entered into a Material Definitive Agreement on September 11, 2024, but the specific details of the agreement are not provided in this summary.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on September 11, 2024.

What is Tharimmune, Inc.'s state of incorporation?

Tharimmune, Inc. is incorporated in Delaware.

What is Tharimmune, Inc.'s Commission File Number?

Tharimmune, Inc.'s Commission File Number is 001-41210.

Where are Tharimmune, Inc.'s principal executive offices located?

Tharimmune, Inc.'s principal executive offices are located at 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.

Filing Stats: 1,058 words · 4 min read · ~4 pages · Grade level 13.6 · Accepted 2024-09-16 09:06:00

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 16, 2024 Tharimmune, Inc. /s/ Randy Milby Randy Milby Chief Executive Officer -3-

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing